Literature DB >> 22693121

Photodynamic therapy of cervical intraepithelial neoplasia 1-3 and human papilloma virus (HMV) infection with methylaminolevulinate and hexaminolevulinate--a double-blind, dose-finding study.

Philipp Soergel1, Gunn Fallås Dahl, Mathias Onsrud, Peter Hillemanns.   

Abstract

INTRODUCTION: Cervical intraepithelial neoplasia (CIN) 1-3 is the precursor of invasive cervical cancer and associated with human papillomavirus infection. Standard treatment is surgical and may be associated with subsequent pregnancy complications. Photodynamic therapy (PDT) of CIN may be an interesting alternative.
MATERIAL AND METHODS: Patients were treated by PDT using hexaminolevulinate (HAL) and methylaminolevulinate in six dose and light groups and two incubation periods in a double-blind setting. Follow-up examinations were performed after 3, 6, and 12 months with histology, cytology, and HPV testing.
RESULTS: We included eight patients with CIN1, 23 with CIN2, and 36 with CIN3. Treatment was well tolerated. HAL 40 mM with 3-hour application turned out to be the most-effective group with 67% (10/15) complete response rate. The combined complete and partial response for patients with CIN2 was 83% (20/24).
CONCLUSION: PDT with CIN may be a safe and effective procedure for CIN treatment.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22693121     DOI: 10.1002/lsm.22041

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  6 in total

Review 1.  Photodynamic therapy: occupational hazards and preventative recommendations for clinical administration by healthcare providers.

Authors:  John D Breskey; Steven E Lacey; Benjamin J Vesper; William A Paradise; James A Radosevich; Michael D Colvard
Journal:  Photomed Laser Surg       Date:  2013-07-16       Impact factor: 2.796

2.  Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol.

Authors:  Fei Chen; Zoltán Novák; Christian Dannecker; Ctirad Mokráš; Long Sui; Youzhong Zhang; Zhixue You; Ling Han; Jinghe Lang; Peter Hillemanns
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

Review 3.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.

Authors:  Demian van Straten; Vida Mashayekhi; Henriette S de Bruijn; Sabrina Oliveira; Dominic J Robinson
Journal:  Cancers (Basel)       Date:  2017-02-18       Impact factor: 6.639

Review 4.  Photodynamic viral inactivation: Recent advances and potential applications.

Authors:  Jace A Willis; Vsevolod Cheburkanov; Giulia Kassab; Jennifer M Soares; Kate C Blanco; Vanderlei S Bagnato; Vladislav V Yakovlev
Journal:  Appl Phys Rev       Date:  2021-06       Impact factor: 19.162

5.  Phototheranostics of Cervical Neoplasms with Chlorin e6 Photosensitizer.

Authors:  Aida Gilyadova; Anton Ishchenko; Artem Shiryaev; Polina Alekseeva; Kanamat Efendiev; Radmila Karpova; Maxim Loshchenov; Victor Loschenov; Igor Reshetov
Journal:  Cancers (Basel)       Date:  2022-01-02       Impact factor: 6.639

Review 6.  Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus.

Authors:  Maryam Dadar; Sandip Chakraborty; Kuldeep Dhama; Minakshi Prasad; Rekha Khandia; Sameer Hassan; Ashok Munjal; Ruchi Tiwari; Kumaragurubaran Karthik; Deepak Kumar; Hafiz M N Iqbal; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-11-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.